top of page

When Will Mounjaro Be Available in New Zealand?

  • Writer: Canaan Aumua
    Canaan Aumua
  • Jan 13
  • 2 min read

Updated: Apr 24


Mounjaro (tirzepatide) has been making global headlines as a promising new medication for weight loss and type 2 diabetes management. As clinical trials and international use continue to show encouraging results, many New Zealanders are asking: when will Mounjaro be available here?


Let’s explore what we currently know about Mounjaro’s availability in NZ, the regulatory pathway, and what options are available in the meantime through trusted providers like Pocket Lab.


What is Mounjaro?


Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication that mimics two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones help regulate appetite, insulin production, and blood sugar — making the drug effective for both weight loss and type 2 diabetes management.


Unlike Wegovy or Ozempic, which only act on the GLP-1 receptor, Mounjaro’s dual-action mechanism may offer even greater metabolic benefits.


Is Mounjaro Available in New Zealand?


Mounjaro is now available in New Zealand via private prescription.


It is not currently funded by Pharmac, which means patients pay for the medication themselves rather than accessing it through the public system.


However, it can be prescribed by a registered NZ GP or specialist — including through telehealth platforms like Pocket Lab.


How to Access Mounjaro in New Zealand


Mounjaro is available via private prescription — it is not publicly funded by Pharmac, so patients cover the cost themselves. Most people access it through: A GP or specialist A telehealth service In practice, many patients now choose online GP services, as it can be faster and more convenient than a traditional clinic visit.


Once prescribed, it is dispensed through pharmacies, and delivery is often available nationwide. Pocket Lab GPs prescribe Mounjaro as part of a medically supervised weight loss care plan. You can get started entirely online — no in-person visit required.


Is Mounjaro Safe?

Yes — when prescribed and monitored by a licensed GP. As with all GLP-1 medications, Mounjaro should be started at a low dose and increased gradually. Side effects are most common during the dose escalation phase and typically improve over time.


Pocket Lab's GPs provide ongoing clinical oversight to ensure your treatment is safe and effective.


Start Mounjaro with Pocket Lab


You no longer need to wait. Mounjaro is available now — and Pocket Lab makes it simple to get started with a GP-led assessment from home. With Pocket Lab's Weight Loss Care Plan, you can:

  • Receive a GP-led assessment to determine if Mounjaro or another GLP-1 medication is right for you.

  • Access prescription-based weight loss support, delivered to your door

  • Get advice on dosing, side effects, and sustainable habit change

  • Have ongoing care and progress tracking, all from home


Final Thoughts

Mounjaro is a powerful tool in the fight against obesity and type 2 diabetes — and it's now available in New Zealand through private prescription. Pocket Lab GPs prescribe Mounjaro as part of a clinically supervised weight loss plan, all from the comfort of your home.


Ready to find out if Mounjaro is right for you? Take our free eligibility quiz and connect with a Pocket Lab GP online.








 
 
bottom of page